Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis
about
Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatmentMouse Models of Rheumatoid ArthritisPreclinical rheumatoid arthritis (autoantibodies): an updated reviewPeriodontitis: from microbial immune subversion to systemic inflammationPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLERegulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.NETosis as Source of Autoantigens in Rheumatoid ArthritisCitrullination in Rheumatoid Arthritis-A Process Promoted by Neutrophil Lysis?Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunityWhen and where does inflammation begin in rheumatoid arthritis?Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patientsAltered B cell signalling in autoimmunity.Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis.NETs: the missing link between cell death and systemic autoimmune diseases?Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.The role of dendritic cells in tissue-specific autoimmunity.Hand to Mouth: A Systematic Review and Meta-Analysis of the Association between Rheumatoid Arthritis and PeriodontitisInsights from populations at risk for the future development of classified rheumatoid arthritisPrevention of rheumatic diseases: strategies, caveats, and future directionsNatural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease.Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' allelesBiomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.The lung may play a role in the pathogenesis of rheumatoid arthritis.Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control studyCharacterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Strategies to predict rheumatoid arthritis development in at-risk populations.Biglycan: a multivalent proteoglycan providing structure and signalsChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity.Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
P2860
Q26786705-7D6F862A-670C-4CBD-BA82-3E5D4C6F013BQ26827745-A8584A97-AF97-4C83-9A3F-0BC282E075C5Q26863441-E481CB46-420D-4218-9952-413C9305FCCFQ26996386-7B81A391-B17C-4AF4-BB6F-04F311110AF0Q27003201-96C9FF04-5854-4A67-B528-8E053E0157C1Q27686770-4E34933A-BAD1-450A-B898-FF05B143123EQ28077803-F998B33E-E523-467D-A6BE-8F510D893523Q28078371-C0327C5D-07A4-4084-A0D2-05FA8EDE7883Q33572468-F7587C51-6A9D-4CFD-82A3-A8C0C3CDDD0EQ33662199-B6216388-9B6E-4718-A24C-B4721FA99C6AQ33717110-673A1B76-F371-400E-A596-4258CD78C646Q33865776-A3B538EC-66F8-4FAC-AD62-209098AA24A8Q33924642-40B5C551-3CF6-4CA3-99C1-318CF1053413Q34026155-79DC357A-CD0F-4923-A379-4468FE683DAAQ34047060-14736D91-E391-407F-ABAE-D655DD6D01E0Q34105680-9D8669FE-D2A3-4846-982A-75550E83FAC2Q34184264-E0359E51-48DB-478F-A0FC-542A231B49AFQ34323566-9E311FE3-792C-47D2-9CEC-8716549CC377Q34347007-5034BD50-7793-4686-A313-82F95667CE65Q34349960-39A45A16-7E9F-4BFD-9CDA-FBDFDEAE46A1Q34422017-962955E1-E1EE-424D-9C72-0C6E84062C6EQ34518022-32A961FB-1D9E-4C2E-B390-EA417C7F6BCEQ34604615-4002916E-C178-41E2-8982-1E62794D7BC5Q34605881-59A469CE-996D-460C-9C93-364BD9DBCF41Q34670001-EB1472C6-28C7-440A-ABE7-F6A7B11E1093Q35130524-08A09154-36CC-4C01-903C-9F6458A1B653Q35136055-551425E7-C02C-42E5-8EC5-BBC103856AC5Q35193733-6E70A47E-A294-4C96-972A-FE71061A7B68Q35210847-68EBBFC6-C6FA-4398-A602-FA7B974A0131Q35533807-6550B222-9250-401B-BCDE-E0B7BFD7E3A7Q35747705-4C6AA90B-77E5-457C-ACEF-A5D6DED09148Q35832816-E1AFDA22-2477-4604-A926-83FEC452F8DEQ36176344-A3E8AC6C-AEC9-4164-94D8-F7F529CF4095Q36297670-D80A7D1F-5976-4332-9171-743A52F0F6DFQ36366153-84C6FDAE-DCCC-47BA-B753-A548B3E8345AQ36481626-9F262255-3361-4010-BF84-4042D417F6F6Q36577396-4DDAC1AD-E422-4E78-B7EA-B0257DAFDE2FQ36588860-8AF4D048-36DF-4D7D-B7FC-40E2DBE9BF4DQ36682022-B1A55AB6-604C-4FD2-8FFD-0059F3FC084BQ36761916-F8AC50E7-99A2-40DA-ACBA-F55E9F3FBFDB
P2860
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@ast
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@en
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@nl
type
label
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@ast
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@en
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@nl
prefLabel
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@ast
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@en
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@nl
P2093
P2860
P1433
P1476
Autoantibody epitope spreading ...... ession to rheumatoid arthritis
@en
P2093
Jeremy Sokolove
Jess D Edison
Jill M Norris
Kevin D Deane
Lauren J Lahey
Lezlie A Derber
Piyanka E Chandra
Reuven Bromberg
V Michael Holers
William H Robinson
P2860
P304
P356
10.1371/JOURNAL.PONE.0035296
P407
P577
2012-05-25T00:00:00Z